ABH Healthcare Limited

Open · NSE SME · Book building IPO

Price band₹96.00 – ₹102.00per equity share · lot of 1,200

Company at a glance · Human reviewed · 26 Aug 2026

The business, in brief

ABH Healthcare Limited is a multi-specialty hospital operator focused on providing specialised tertiary medical care in Tier 3 cities within the state of Punjab, operating under the 'Anil Baghi Hospital' brand with 150 beds.

Customer concentration
60.05%
top 10 customers
Total borrowings
₹523.36 cr
Fiscal 2026
Products & services
  1. Cardiac sciences
  2. Neurology
  3. Minimally invasive spine and brain surgeries
  4. Gastroenterology
  5. Laparoscopic and bariatric surgery
  6. Urology
  7. Pulmonology
  8. Nephrology
+11 more in the RHP
Healthcare / Hospital services
IPO timetable
01IPO opens23 Aug 2026 · Sunday
02IPO closes26 Aug 2026 · Wednesday
03Allotment27 Aug 2026 · Thursday*
04Refunds30 Aug 2026 · Sunday*
05Shares credited30 Aug 2026 · Sunday*
06Listing day31 Aug 2026 · Monday*

* Estimated date based on the standard exchange timeline. Unmarked dates are exchange-reported.

Valid application sizes
Individual investors entry1 lots · 1,200 sh₹1,22,400.00
sNII entry2 lots · 2,400 sh₹2,44,800.00
sNII ceiling8 lots · 9,600 sh₹9,79,200.00
bNII entry9 lots · 10,800 sh₹11,01,600.00

Calculated at the upper band of ₹102.00 per share. Amounts exclude blocked-funds variation.

Prospectus dossier

Numbers, plans & pressure points

A focused reading of the company's reported financials, planned use of proceeds, business strengths and material risks.

A multi-year view

Figures retain the units reported in the RHP
Fiscal yearRevenueProfit after taxOperating cash flowBorrowingsNet worth
Fiscal 2026₹525.07 cr₹56.39 cr₹21.11 cr₹523.36 cr₹173.37 cr
Fiscal 2025₹492.67 cr₹53.47 cr₹35.44 cr₹116.92 cr
Fiscal 2024₹413.8 cr₹16.56 cr₹8.88 cr₹63.53 cr

01 Use of funds

Where the
money goes.

03stated objects
in the filing

  1. Repayment / prepayment, in part or full, of certain of our borrowingsRHP p. 85

  2. Funding our Working Capital RequirementsRHP p. 85

  3. Funding inorganic growth through unidentified acquisitions and general corporate purposesRHP p. 85

02 Growth case

What could drive
the business.

08signals found
in the filing

  • Doctor led professional management team with proven execution capabilitiesRHP p. 96

  • Delivering quality clinical care by attracting and retaining experienced and renowned cliniciansRHP p. 96

  • Diversified operations across clinical specialties, payor mix and hospitalsRHP p. 96

  • Robust operating infrastructure including information technology and modern equipmentsRHP p. 96

  • Track record of stable operating and financial performance and growthRHP p. 96

  • Rising income and affordabilityRHP p. 119

  • Growing elderly population, changing disease patternsRHP p. 119

  • Better awareness of wellness, preventive care and diagnosisRHP p. 119

03 Risk factors

Read the downside first.

Selected material risks disclosed in the RHP. Read these before the upside case. This summary is not a substitute for the prospectus.

01
OPERATIONS

Limited operating history

Our Company has been specifically formed for the purpose of acquisition of the business of M/s. Anil Baghi Hospital (sole proprietorship concern of one of our Promoters), thus we have limited operating history as a Company which may make it difficult for investors to evaluate our historical performance or future prospects.

02
GEOGRAPHY

Geographical concentration in Ferozepur, Punjab

Our revenues are significantly dependent on our only hospital in Ferozepur, Punjab, any change in the economic or political circumstances in or around the areas of Ferozepur, could materially affect our business, financial condition and results of operations.

03
SUPPLIER

Dependence on limited suppliers and key third-party payers

We rely on certain third parties, including suppliers, and also enter into contracts with third-party payers such as insurance companies, third party administrators, corporations and government departments. Termination, non-renewal or any breach of the conditions of such contracts could have a material adverse impact on our business, financial condition and results of operations.

04
DEBT

High debt-equity ratio and funding risks

We have a high debt-equity ratio and may face certain funding risks. Any further increase in borrowings may have a material adverse effect on our business, financial condition and results of operations. Further, if we do not generate sufficient amount of cash flow from operations, our liquidity and ability to service our indebtedness could be adversely affected.

05
LITIGATION

Exposure to medical malpractice claims

We are exposed to legal claims and regulatory actions arising from the provision of healthcare services and may be subject to liabilities arising from claims of malpractice and medical negligence which could materially and adversely affect our reputation and prospects.

Live issue demand

The book, in motion

No exchange tape for this issue yet

Full subscription tape →